Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
i values » _ values (Expand Search)
can also » may also (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
Showing 81 - 100 results of 58,147 for search '(((( i values decrease ) OR ( can also increased ))) OR ( ((c large) OR (i large)) decrease ))', query time: 1.71s Refine Results
  1. 81
    Increase in concordance statistic with more HbA<sub>1c</sub> values of subjects on cumulative time intervals.

    Increase in concordance statistic with more HbA<sub>1c</sub> values of subjects on cumulative time intervals. by Clarence Tee (14486026)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 82
    <i>C</i>. <i>elegans</i> nictation ratio decreases over the course of our 30 min videos.

    <i>C</i>. <i>elegans</i> nictation ratio decreases over the course of our 30 min videos. by Patrick D. McClanahan (2385076)

    Published 2023
    Save to List
    Saved in:
  3. 83
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 85
    Decreased recovery times were observed after repeated handling and anesthesia sessions.

    Decreased recovery times were observed after repeated handling and anesthesia sessions. by Lingzhi Wang (114519)

    Published 2019
    Save to List
    Saved in:
  6. 86
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 88
    Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File).

    Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File). by Farrokh Habibzadeh (12256529)

    Published 2025
    Save to List
    Saved in:
  9. 89
    Under-five, post-neonatal and child mortality among children admitted to pediatrics ward of Asella Teaching and Referral Hospital, January 2020 G.C.

    Under-five, post-neonatal and child mortality among children admitted to pediatrics ward of Asella Teaching and Referral Hospital, January 2020 G.C. by Firaol Lemessa Kitila (11402219)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 90
    Data Sheet 2_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.pdf

    Data Sheet 2_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.pdf by Tyler W. Ferris (22481194)

    Published 2025
    “…Despite confirming a ~400-kb deletion in the k1C family of both edited lines encompassing seven active genes, no significant decrease was observed in k1C expression or compensatory increase in non-kafirin proteins. …”
    Save to List
    Saved in:
  11. 91
    Potential distribution of <i>Atta</i> species.

    Potential distribution of <i>Atta</i> species. by Jorge A. Gómez-Díaz (17048305)

    Published 2023
    Save to List
    Saved in:
  12. 92
    Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs kROC estimators under equal sample sizes ().

    Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs kROC estimators under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

    Published 2025
    Save to List
    Saved in:
  13. 93
    Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs BP6 estimators under equal sample sizes ().

    Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs BP6 estimators under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

    Published 2025
    Save to List
    Saved in:
  14. 94
    Average self-reported physical health ratings before or during the COVID-19 pandemic among individuals who engaged during the pandemic in more than 3 (A), 4 (B), or 5 (C) positive health behaviors (dark blue lines) compared to those who did not (light blue lines).

    Average self-reported physical health ratings before or during the COVID-19 pandemic among individuals who engaged during the pandemic in more than 3 (A), 4 (B), or 5 (C) positive... by Elie Mulhem (22537863)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    Posterior, mid-posterior, central, and mid-anterior corpus callosal volume significantly decreased with increasing risk of environmental lead exposure.

    Posterior, mid-posterior, central, and mid-anterior corpus callosal volume significantly decreased with increasing risk of environmental lead exposure. by Andrew T. Marshall (10159199)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 96
    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected African countries.

    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

    Published 2024
    Save to List
    Saved in:
  17. 97
    Parameter values in the one-cortical-column model.

    Parameter values in the one-cortical-column model. by Farhad Razi (22076077)

    Published 2025
    Save to List
    Saved in:
  18. 98
    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected South American countries.

    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)

    Published 2024
    Save to List
    Saved in:
  19. 99
    “p-value” results of two-way ANOVA tests.

    “p-value” results of two-way ANOVA tests. by Sally V. Irwin (4521733)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 100
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: